Is It Legit?
Insufficient Evidence
“NMN reverses aging”
Educational, not medical advice. Always consult a qualified healthcare provider before changing your diet, supplements, or routine. Full disclaimer.
What the science says
NMN, short for nicotinamide mononucleotide, is a supplement the body converts into NAD+, a molecule every cell needs to produce energy, and no human trial has yet shown it reverses ageing. Animal studies are the strong part of the story: NMN raises NAD+ levels and has extended lifespan in mice by 5 to 10% in some studies. In humans, the evidence as of 2024 is limited to a handful of small, short trials that measured blood markers such as insulin sensitivity - how readily the body responds to insulin, the hormone that clears sugar from the blood - not ageing itself or how long people live.
Full analysis
In mice, NMN and a related compound called NR reverse several signs of ageing, including muscle decline, slower metabolism and reduced insulin sensitivity (the body responding poorly to insulin, the hormone that clears sugar from the blood), and extend lifespan by 5 to 10% in some studies. The proposed mechanism is restoring NAD+, a molecule cells need for energy, which activates repair proteins called SIRT1 and SIRT3.
Human data are far more limited. A 2021 trial gave postmenopausal women with prediabetes - blood sugar higher than normal, but not yet high enough to count as diabetes - 250mg of NMN daily for 10 weeks, and found it improved how well their muscle responded to insulin. That is a real but narrow result in one specific group, not evidence of reversed ageing.
A separate 2022 trial found NMN raised blood NAD+ levels in a dose-dependent way, meaning the larger the dose the larger the rise, but it tracked no health outcome.
No trial has measured whether NMN reverses a marker of biological ageing - a body measurement that reflects how worn your cells are rather than how many birthdays you have had - or extends human lifespan, and this evidence does not apply to healthy adults outside the small groups studied so far.
Short-term use at the doses tested, roughly 250 to 1,000mg a day, appears safe so far, but long-term safety is unknown. NAD+ also fuels cancer cell growth, so whether raising it affects cancer risk in someone with an undetected tumour remains an open question.
Key studies
The studies that carry the verdict.
[1]Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Yoshino M et al. · Science · 2021
In postmenopausal women with prediabetes, taking 250mg of NMN a day for 10 weeks improved how well their muscles responded to insulin, but the trial was small and limited to this one group of women.
View paper[2]The Science Behind NMN-A Stable, Reliable NAD+Activator and Anti-Aging Molecule
Shade C · Integrative Medicine (Encinitas) · 2020
A review article rather than a trial, so it tests nothing itself. It is included here to show what the wider NMN literature looked like in 2020, and it carries no human outcome data of its own.
View paper